Merck Insomnia Drug Safe Only in Low Doses

May 23 (Bloomberg) -- Merck & Co.’s experimental insomnia drug, meant to be a less disruptive alternative to Sanofi’s Ambien sleeping pill, is safe only at lower doses, U.S. regulatory advisers said. Olivia Sterns reports on Bloomberg Television's "Bottom Line." (Source: Bloomberg)
The Growth of the Action Camera Market
55:50 - Ricoh Imaging's Jim Malcolm, iON Worldwide CEO Giovanni Tomaselli and 360fly CEO Peter Adderton discuss the growth of the action camera market with Bloomberg's Emily Chang on "Bloomberg West." (Source: Bloomberg)
  • Using Virtual Reality to Change the Face of Journalism
  • 360Fly: Pioneers of Spherical Video Market
  • Ricoh: The Future Potential for 360 Degree Cameras